Berkshire Asset Management LLC Amgen Inc Transaction History

Berkshire Asset Management LLC

$2 Billion
Q2 2024

A detailed history of Berkshire Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Berkshire Asset Management LLC holds 29,474 shares of AMGN stock, worth $9.44 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

29,474

Previous 29,439 0.12%

Holding current value

$9.44 Million

Previous $8.37 Million 10.02%

% of portfolio

0.46%

Previous 0.44%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $9,196 - $11,175	35 Added 0.12%	29,474 $9.21 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $63,453 - $76,596	-236 Reduced 0.8%	29,439 $8.37 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $50,372 - $56,826	-197 Reduced 0.66%	29,675 $8.55 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $78,714 - $97,725	-360 Reduced 1.19%	29,872 $8.03 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $99,635 - $117,817	465 Added 1.56%	30,232 $6.71 Million
Q1 2023 Jun 06, 2023	SELL	$225.79 - $275.2 $52,157 - $63,571	-231 Reduced 0.77%	29,767 $7.2 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $46,264 - $58,784	-202 Reduced 0.67%	29,998 $7.88 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $19.4 Million - $21.8 Million	-86,263 Reduced 74.07%	30,200 $6.81 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $436,041 - $485,238	1,890 Added 1.65%	116,463 $28.3 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $598,826 - $662,458	2,731 Added 2.44%	114,573 $27.7 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $340,084 - $389,196	-1,710 Reduced 1.51%	111,842 $25.2 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $238,803 - $279,787	1,125 Added 1.0%	113,552 $24.1 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $1.1 Million - $1.22 Million	4,700 Added 4.36%	112,427 $27.4 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1.37 Million - $1.6 Million	-6,193 Reduced 5.44%	107,727 $26.8 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1.9 Million - $2.26 Million	8,779 Added 8.35%	113,920 $26.2 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1.75 Million - $1.94 Million	-7,441 Reduced 6.61%	105,141 $26.7 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $316,100 - $387,898	-1,598 Reduced 1.4%	112,582 $26.6 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $826,822 - $1.1 Million	4,537 Added 4.14%	114,180 $23.1 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $670,749 - $862,144	-3,545 Reduced 3.13%	109,643 $26.4 Million
Q3 2019 Oct 07, 2019	SELL	$174.11 - $208.62 $2.89 Million - $3.47 Million	-16,627 Reduced 12.81%	113,188 $21.9 Million
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $8,835 - $10,356	53 Added 0.04%	129,815 $23.9 Million
Q1 2019 Apr 16, 2019	BUY	$180.87 - $203.88 $13,203 - $14,883	73 Added 0.06%	129,762 $24.7 Million
Q4 2018 Jan 24, 2019	BUY	$178.4 - $208.25 $137,189 - $160,144	769 Added 0.6%	129,689 $25.2 Million
Q3 2018 Oct 12, 2018	BUY	$185.29 - $208.89 $1.02 Million - $1.15 Million	5,490 Added 4.45%	128,920 $26.7 Million
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $1 Million - $1.13 Million	-6,038 Reduced 4.66%	123,430 $22.8 Million
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $270,240 - $315,810	1,595 Added 1.25%	129,468 $22.1 Million
Q4 2017 Jan 17, 2018	BUY	$168.79 - $188.59 $1.72 Million - $1.92 Million	10,162 Added 8.63%	127,873 $22.2 Million
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $19.7 Million - $22.5 Million	117,711	117,711 $21.9 Million

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Account

Berkshire Asset Management LLC Amgen Inc Transaction History